Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

170
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
170
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
2.5K
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
Chronic Obstructive Pulmonary Disease01:22

Chronic Obstructive Pulmonary Disease

1.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K
Assessment of Diffusion and Perfusion01:17

Assessment of Diffusion and Perfusion

966
Understanding and evaluating diffusion and perfusion is critical in assessing a patient's respiratory and circulatory health. These processes play key roles in maintaining the body's internal environment, ensuring that tissues receive adequate oxygen while waste products are efficiently removed.
The Role of Diffusion in Respiration
Diffusion is the process by which molecules move from an area of higher concentration to an area of lower concentration. In the respiratory system, this...
966
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

188
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
188

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Social media activities to enhance the visibility of long-term invasive ventilation: A content and visibility analysis from the PRiVENT study.

PloS one·2026
Same author

Development of a Physician-Independent Screening for Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Case-Control and Cohort Study.

Respiration; international review of thoracic diseases·2026
Same author

Tracheostomy timing and weaning outcomes following prolonged mechanical ventilation.

BMC pulmonary medicine·2026
Same author

Amikacin exposure in MDR-TB patients in Uganda: Revisiting old drugs in a new era of resistance - A pharmacokinetic assessment.

New microbes and new infections·2026
Same author

Sex-Specific Phenotypes and Outcomes in Non-Idiopathic Pulmonary Fibrosis Interstitial Lung Disease: Results from the INSIGHTS-ILD Registry.

Respiration; international review of thoracic diseases·2026
Same author

How malicious AI swarms can threaten democracy.

Science (New York, N.Y.)·2026
Same journal

Clofazimine use for nontuberculous mycobacterial infections: 10-year experience in Belgium.

BMC pulmonary medicine·2026
Same journal

Development and multicenter validation of machine learning models for 28-day mortality in critically ill patients with acute exacerbation of chronic obstructive pulmonary disease.

BMC pulmonary medicine·2026
Same journal

Study protocol: a 52-week, multicentre, observational, prospective study on the use of a smart platform connected to a single-inhaler triple therapy (ICS/LABA/LAMA) to evaluate effectiveness on treatment adherence and inhaler technique in patients with poorly controlled asthma.

BMC pulmonary medicine·2026
Same journal

Clinical characteristics and risk factors for mortality in pulmonary mucormycosis among patients with non-hematologic malignancies.

BMC pulmonary medicine·2026
Same journal

Characterization of mucus plugging in patients with chronic obstructive pulmonary disease: additional clinical significance of asthma-like features.

BMC pulmonary medicine·2026
Same journal

Decoding the shared genetic liability of lower respiratory tract infections via genomic structural equation modeling.

BMC pulmonary medicine·2026
See all related articles

Related Experiment Video

Updated: Jun 21, 2025

Expired CO2 Measurement in Intubated or Spontaneously Breathing Patients from the Emergency Department
07:52

Expired CO2 Measurement in Intubated or Spontaneously Breathing Patients from the Emergency Department

Published on: January 29, 2011

16.2K

Hypercapnia and lung function parameters in chronic obstructive pulmonary disease.

Lukas Gernhold1, Claus Neurohr2,3, Konstantinos Tsitouras2

  • 1Department of Pulmonology and Respiratory Medicine, Lung Center Stuttgart - Schillerhoehe Lung Clinic GmbH, affiliated with Robert-Bosch-Hospital GmbH (Bosch Health Campus), Auerbachstr. 110, Stuttgart, 70376, Germany. lukas.gernhold@rbk.de.

BMC Pulmonary Medicine
|July 16, 2024
PubMed
Summary
This summary is machine-generated.

For advanced chronic obstructive pulmonary disease (COPD), forced vital capacity (FVC) and forced expiratory volume in 1 second (FEV1) can predict chronic hypercapnia. These spirometry measures offer valuable insights into disease progression and patient outcomes.

Keywords:
COPDHypercapniaLung function parametersPulmonary function tests

More Related Videos

MRI Mapping of Cerebrovascular Reactivity via Gas Inhalation Challenges
09:33

MRI Mapping of Cerebrovascular Reactivity via Gas Inhalation Challenges

Published on: December 17, 2014

14.0K
Combining Volumetric Capnography And Barometric Plethysmography To Measure The Lung Structure-function Relationship
08:25

Combining Volumetric Capnography And Barometric Plethysmography To Measure The Lung Structure-function Relationship

Published on: January 8, 2019

9.4K

Related Experiment Videos

Last Updated: Jun 21, 2025

Expired CO2 Measurement in Intubated or Spontaneously Breathing Patients from the Emergency Department
07:52

Expired CO2 Measurement in Intubated or Spontaneously Breathing Patients from the Emergency Department

Published on: January 29, 2011

16.2K
MRI Mapping of Cerebrovascular Reactivity via Gas Inhalation Challenges
09:33

MRI Mapping of Cerebrovascular Reactivity via Gas Inhalation Challenges

Published on: December 17, 2014

14.0K
Combining Volumetric Capnography And Barometric Plethysmography To Measure The Lung Structure-function Relationship
08:25

Combining Volumetric Capnography And Barometric Plethysmography To Measure The Lung Structure-function Relationship

Published on: January 8, 2019

9.4K

Area of Science:

  • Pulmonary Medicine
  • Respiratory Physiology
  • Chronic Disease Management

Background:

  • Advanced chronic obstructive pulmonary disease (COPD) can lead to hypercapnia due to severe bronchial obstruction and lung hyperinflation.
  • Non-invasive ventilation (NIV) is the standard of care for reducing mortality in COPD patients with hypercapnia.
  • Identifying predictors of chronic hypercapnia is crucial for managing advanced COPD.

Purpose of the Study:

  • To evaluate pulmonary function parameters as predictors of chronic hypercapnia in advanced COPD patients.
  • To assess the diagnostic accuracy of spirometry (FVC, FEV1), body plethysmography (RV, TLC), and diffusion capacity (DCO-SB, DCO-VA) for predicting chronic hypercapnia.

Main Methods:

  • A retrospective observational study included 423 COPD patients.
  • Receiver operating characteristic (ROC) curve analysis assessed diagnostic accuracy (AUROC).
  • Univariable and multivariable logistic regression determined independent associations with chronic hypercapnia (OR, 95%CI).

Main Results:

  • Forced vital capacity (FVC%) and forced expiratory volume in 1 second (FEV1%) showed reasonable predictive accuracy for chronic hypercapnia (AUROC 0.77 and 0.75, respectively).
  • Lung diffusion capacity (DCO-SB%) performed poorly in prediction (AUROC 0.64).
  • FVC% (OR 0.95) and FEV1% (OR 0.97) were independently associated with chronic hypercapnia. Optimal thresholds were FVC 56% and FEV1 33% of predicted values.

Conclusions:

  • Routinely collected pulmonary function parameters, specifically FVC% and FEV1%, can predict chronic hypercapnia in COPD.
  • These spirometry measures are valuable tools for monitoring disease progression and identifying patients at risk of hypercapnia.